Blar i NTNU Open på forfatter "Hansen, Inger Johanne Widding"
-
A comparison of disease burden in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis
Michelsen, Brigitte; Fiane, Ragnhild; Diamantopoulos, Andreas P; Soldal, Dag; Hansen, Inger Johanne Widding; Sokka, Tuulikki; Kavanaugh, Arthur; Haugeberg, Glenn (Journal article; Peer reviewed, 2015)Objective: The main objective of this study was to compare disease burden in rheumatoid arthritis (RA), psoriatic arthritis (PsA) and axial spondyloarthritis (ax-SpA). Methods: In this cross-sectional study, all ... -
Effectiveness and Persistence in SB4- and Reference Etanercept–Treated Rheumatoid Arthritis Patients in Ordinary Clinical Practice in Norway
Haugeberg, Glenn; Bakland, Gunnstein; Rødevand, Erik; Hansen, Inger Johanne Widding; Diamantopoulos, Andreas P; Pripp, Are Hugo (Peer reviewed; Journal article, 2023)Objective Biosimilars represent cost-effective alternatives to reference biologic disease-modifying antirheumatic drugs. Our objective was to compare drug effectiveness and drug persistence in the treatment of rheumatoid ... -
Ten years of change in clinical disease status and treatment in rheumatoid arthritis: Results based on standardized monitoring of patients in an ordinary outpatient clinic in southern Norway
Haugeberg, Glenn; Hansen, Inger Johanne Widding; Soldal, Dag; Sokka, Tuulikki (Journal article; Peer reviewed, 2015)Introduction In the new millennium, clinical outcomes in patients with rheumatoid arthritis (RA) have improved. Despite a large number of register data, there is a lack of data reflecting the entire outpatient RA ... -
Ten years of follow-up data in psoriatic arthritis: Results based on standardized monitoring of patients in an ordinary outpatient clinic in southern Norway
Haugeberg, Glenn; Michelsen, Brigitte; Tengesdal, Stig; Hansen, Inger Johanne Widding; Diamantopoulos, Andreas P; Kavanaugh, Arthur (Journal article; Peer reviewed, 2018)Background: Over the last decade, a treat-to-target (T2T) strategy has been recommended for psoriatic arthritis (PsA) and new treatment options have become available. There is a lack of data on PsA regarding any changes ...